Whitehawk Therapeutics, Inc. Common Stock WHWK Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$115.81M-462% | -$20.6M-31.9% | -$15.62M-49.9% | -$10.42M-138% | $27.61M+143% | ||
| $22.9K-71.0% | $78.9K-36.8% | $124.9K-24.8% | $166K-17.1% | $200.3K+3.6% | ||
| $10.39M+5.2% | $9.87M+5.7% | $9.34M+1.8% | $9.18M+2.8% | $8.93M-17.6% | ||
| -$107.78M-10.6% | -$97.43M-2.3% | -$95.25M+0.3% | -$95.56M-84.6% | -$51.76M+13.1% | ||
| —— | —— | —— | $926K-36.8% | $1.47M-11.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $95.34M+73,239% | ||
| —— | —— | —— | —— | $173.73M+608% | ||
| -$107.78M-10.0% | -$97.99M-2.1% | -$95.99M+0.5% | -$96.49M-81.3% | -$53.23M+13.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Whitehawk Therapeutics, Inc. Common Stock generate?
- Whitehawk Therapeutics, Inc. Common Stock (WHWK) generated -$107.8M in operating cash flow over the trailing twelve months.
- What is Whitehawk Therapeutics, Inc. Common Stock's free cash flow?
- After $738.0K of capital expenditures, Whitehawk Therapeutics, Inc. Common Stock's free cash flow was -$107.8M over the trailing twelve months, down 102.5% year over year.
- Where does Whitehawk Therapeutics, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Whitehawk Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.